HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nobuhiko Uoshima Selected Research
Nobuhiko Uoshima Research Topics
Disease
20
Multiple Myeloma
05/2024 - 11/2010
9
Neoplasms (Cancer)
01/2023 - 04/2006
9
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2022 - 07/2003
6
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 04/2007
6
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2018 - 07/2003
4
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2024 - 01/2018
4
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2024 - 01/2002
4
Philadelphia Chromosome
11/2023 - 04/2009
4
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 09/2010
4
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018 - 04/2009
3
Aplastic Anemia (Anemia, Hypoplastic)
12/2023 - 03/2019
3
Leukemia
10/2015 - 06/2011
2
Thrombocytopenia (Thrombopenia)
02/2024 - 01/2002
2
COVID-19
12/2023 - 01/2023
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2023 - 04/2009
2
Disseminated Intravascular Coagulation
01/2019 - 01/2012
2
Encephalitis (Encephalitis, Rasmussen)
01/2018 - 09/2013
2
Chromosome Aberrations (Chromosome Abnormalities)
01/2018 - 05/2017
2
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2017 - 05/2017
2
Hematologic Neoplasms (Hematological Malignancy)
01/2016 - 01/2012
2
Lymphoma (Lymphomas)
09/2010 - 01/2007
1
Cytopenia
02/2024
1
Residual Neoplasm
11/2023
1
Anemia
09/2023
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2023
1
Extranodal NK-T-Cell Lymphoma
10/2022
1
Frailty
03/2022
1
Hypertension (High Blood Pressure)
01/2022
1
Myeloid Sarcoma (Chloroma)
01/2021
1
Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2019
1
Polycythemia (Erythrocytosis)
12/2016
1
Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
03/2016
1
Stevens-Johnson Syndrome (Lyell's Syndrome)
03/2016
1
Disease Progression
12/2015
1
Large Granular Lymphocytic Leukemia
10/2015
1
Lymphocytosis
10/2015
1
Hyponatremia
06/2015
1
Critical Illness (Critically Ill)
06/2015
1
Central Pontine Myelinolysis
06/2015
1
Pathologic Complete Response
06/2015
1
Thrombotic Thrombocytopenic Purpura
01/2013
Drug/Important Bio-Agent (IBA)
10
Rituximab (Mabthera)
FDA Link
01/2023 - 04/2007
9
Dexamethasone (Maxidex)
FDA Link
Generic
01/2022 - 11/2010
7
Lenalidomide (CC 5013)
FDA Link
01/2022 - 01/2015
5
Bortezomib (Velcade)
FDA Link
01/2022 - 11/2010
5
Dasatinib (BMS 354825)
FDA Link
01/2018 - 04/2009
4
carfilzomib
IBA
03/2022 - 01/2022
4
Bendamustine Hydrochloride
FDA Link
01/2022 - 09/2010
3
Azacitidine (5 Azacytidine)
FDA Link
02/2024 - 01/2021
3
Melphalan (Alkeran)
FDA Link
Generic
01/2020 - 04/2014
3
Prednisolone (Predate)
FDA Link
Generic
01/2020 - 04/2014
3
Imatinib Mesylate (Gleevec)
FDA Link
10/2015 - 04/2009
2
pomalidomide
IBA
05/2024 - 05/2018
2
daratumumab
IBA
03/2024 - 01/2022
2
elotuzumab
IBA
03/2024 - 01/2023
2
romiplostim
FDA Link
12/2023 - 01/2021
2
Monoclonal Antibodies
IBA
01/2023 - 04/2007
2
CCAAT-Enhancer-Binding Protein-alpha
IBA
11/2022 - 01/2016
2
Phosphotransferases (Kinase)
IBA
11/2019 - 10/2018
2
Thrombomodulin
IBA
01/2019 - 01/2012
2
Nucleophosmin
IBA
10/2018 - 01/2016
2
Tacrolimus (Prograf)
FDA Link
Generic
12/2004 - 07/2003
1
isatuximab
IBA
05/2024
1
Bispecific Antibodies
IBA
03/2024
1
Chimeric Antigen Receptors
IBA
03/2024
1
Vaccines
IBA
12/2023
1
Messenger RNA (mRNA)
IBA
12/2023
1
RNA (Ribonucleic Acid)
IBA
11/2023
1
Serum Albumin
IBA
09/2023
1
Cholesterol
IBA
09/2023
1
obinutuzumab
IBA
01/2023
1
Neutralizing Antibodies
IBA
01/2023
1
Anthracyclines
IBA
10/2022
1
Proteasome Inhibitors
IBA
01/2022
1
Interleukin-6 (Interleukin 6)
IBA
01/2022
1
Integrins
IBA
07/2021
1
ixazomib
IBA
04/2021
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
03/2019
1
thymoglobulin
FDA Link
03/2019
1
defibrotide
IBA
01/2019
1
Foscarnet
FDA Link
Generic
01/2018
1
Core Binding Factors (Core-Binding Factor)
IBA
10/2017
1
Erythropoietin Receptors (Erythropoietin Receptor)
IBA
12/2016
1
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
12/2016
1
mogamulizumab
IBA
03/2016
1
Thalidomide (Thalomid)
FDA Link
01/2016
1
Tyrosine Kinase Inhibitors
IBA
10/2015
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
06/2015
1
Methylprednisolone
FDA Link
Generic
06/2015
1
Vindesine (Vindesin)
IBA
06/2015
1
pirarubicin
IBA
06/2015
1
Electrolytes
IBA
06/2015
1
DNA (Deoxyribonucleic Acid)
IBA
09/2013
1
Galectin 3 (LGALS3)
IBA
10/2011
Therapy/Procedure
26
Therapeutics
03/2024 - 01/2007
11
Drug Therapy (Chemotherapy)
11/2021 - 04/2006
7
Stem Cell Transplantation
11/2021 - 07/2003
3
Hematopoietic Stem Cell Transplantation
08/2022 - 01/2019
3
Cell Transplantation
01/2016 - 03/2011
2
Transplantation
02/2024 - 01/2018